Menu Search
Equities

Guardion Health Sciences Inc

0QTA:BER

Guardion Health Sciences Inc

Actions
  • Price (EUR)8.85
  • Today's Change0.10 / 1.14%
  • Shares traded-1.00
  • 1 Year change+52.59%
  • Beta--
Data delayed at least 15 minutes, as of Jun 05 2024 09:50 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. It sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.

  • Revenue in USD (TTM)12.06m
  • Net income in USD-5.12m
  • Incorporated2015
  • Employees9.00
  • Location
    Guardion Health Sciences Inc2925 Richmond Avenue, Suite 1200HOUSTON 77098United StatesUSA
  • Phone+0 (1800) 873-5141
  • Fax+1 (858) 630-5543
  • Websitehttps://www.guardionhealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.